Press release
Global Kidney Cancer Drugs Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
SummaryThe Global Kidney Cancer Drugs Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Kidney Cancer Drugs industry.
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Kidney Cancer Drugs market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.s
Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Kidney Cancer Drugs industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.
This report studies the Kidney Cancer Drugs market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed. The different types of kidney cancer (such as RCC and TCC) develop in different ways, meaning that the diseases have different long term outcomes, and need to be staged and treated in different ways. RCC is responsible for approximately 80% of primary renal cancers, and TCC accounts the majority of the remainder.
Biological therapies are drugs which are used to kill cancer cells or stop them from growing. Biological therapies are used to try to shrink or control advanced kidney cancer and help people to live longer. You may be given biological therapies for kidney cancer that has already spread, or is at high-risk of coming back after surgery.
The global Kidney Cancer Drugs market was xx million US$ in 2017 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2018 and 2025.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Kidney Cancer Drugs in these regions, from 2013 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Bayer
Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics
ArQule
AVEO Pharmaceuticals
Bionomics
Bristol-Myers Squibb
Cerulean Pharma
Exelixis
Genentech
immatics biotechnologies
Immunicum
Ono Pharmaceutical
Onyx Therapeutics
Oxford BioMedica
Prometheus Laboratories
Seattle Genetics
Taiwan Liposome
Tracon Pharmaceuticals
Wilex
By the product type, the market is primarily split into
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
By the end users/application, this report covers the following segments
Renal cell carcinoma (RCC)
Transitional cell carcinoma (TCC)
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Kidney Cancer Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Kidney Cancer Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Kidney Cancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Kidney Cancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Kidney Cancer Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Kidney Cancer Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Kidney Cancer Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Kidney Cancer Drugs market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Click to view the full report: http://www.qyresearchglobal.com/goods-1776997.html
Table of Contents
1 Kidney Cancer Drugs Market Overview
2 Global Kidney Cancer Drugs Market Competition by Company
3 Kidney Cancer Drugs Company Profiles and Sales Data
4 Kidney Cancer Drugs Market Status and Outlook by Regions
5 Kidney Cancer Drugs Application/End Users
6 Global Kidney Cancer Drugs Market Forecast
7 Kidney Cancer Drugs Upstream Raw Materials
8 Marketing Strategy Analysis, Distributors
9 Research Findings and Conclusion
Note:We also offer
Germany/Korea/Australia/Brazil/Russia/India/Indonesia/ Malaysia/Saudi Arabia/Middle East/Europe/Asia/Asia-Pacific/Southeast Asia/North America/ Latin America/South America/AMER/EMEA/Africa etc Countries/Regions and Sales/Industry Versions Respectively
Would like to place an order or any question, please feel free to contact me~O(n_n)O~
QY Research, INC.
17890 Castleton, Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: sales@qyresearchglobal.com
Web: http://www.qyresearchglobal.com/
Today, QYResearch brand has become the consulting industry with quality assurance consulting brand. The company has 1100 global well-known customers, covering energy automobile pharmaceutical chemical agriculture more than 30 industries, services from the data analysis and recommendations-Consulting landing one-stop solution, and research regions cover global and China,it is the first choice and worth trusted consulting brand in China business consulting services.
QY Research, INC.
17890 Castleton, Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: sales@qyresearchglobal.com
Web: http://www.qyresearchglobal.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Kidney Cancer Drugs Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application here
News-ID: 1176093 • Views: …
More Releases from QYResearch Group
3D Scanner Market Future Forecast 2018 – 2025: Latest Analysis by QY Research
In its recently published report, QY Research has provided unique insights about global 3D Scanner market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments of the global 3D Scanner market.
Request a Sample of this…
Carbonyl Iron Powder and Ultra Fine Iron Powder Market Demand by 2025: QY Resear …
This recently published report examines the global Carbonyl Iron Powder and Ultra Fine Iron Powder market for the projected period of 7-years, i.e. between 2018 and 2025. The report highlights the accomplishments and opportunities lies in the market throughout the forecasted period. The report offers the thorough information about the overview and the scope of the global Carbonyl Iron Powder and Ultra Fine Iron Powder market along with its drivers, restraints, and…
Global Artificial Disc Replacement Industry Research Report, Growth Trends and C …
This study focuses on the production side and consumption side of Artificial Disc Replacement, presents the global Artificial Disc Replacement market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
In terms of production side, this report researches the Artificial Disc Replacement capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption…
Whole Homeopathic Medicine Market Size, Share, Development by 2013-2025 - QY Res …
This report focuses on the global Homeopathic Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Homeopathic Medicine development in United States, Europe and China.
Homeopathy is a field of alternative medicine, introduced by Samuel Hahnemann in 1976. It works on the principle of similarity of symptoms i.e. a substance causing symptoms of disease in healthy individual will show same symptoms in…
More Releases for Kidney
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
Kidney Cancer Association Partners with Conquer Cancer Foundation to Fund Kidney …
For over a decade, the Kidney Cancer Association has assisted with funding the Conquer Cancer Foundation of ASCO's Young Investigator Award. The award provides funding to promising doctors to pursue careers in kidney cancer research.
“Conquer Cancer truly appreciates the generous and ongoing support of the Kidney Cancer Association as we work together to advance cutting-edge research and treatments for kidney cancer. We value this partnership which supports kidney cancer research…
Kidney Cancer Drugs Market: Rising Incidence of Kidney Cancer Expected to Boost …
With only a handful of large vendors accounting collectively for a large share, the vendor landscape of the global market for kidney cancer drugs can be viewed as largely consolidated and tough to crack for new vendors, observes Transparency Market Research in a recent report. The level of competition among leading players is also quite stiff.
Among the leading players, Pfizer, Inc. accounted for the maximum share in the overall market…
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA
Major scientific sessions:
Kidney Fluid, Electrolytes, Acid-Base Disorders
Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders
Chronic Kidney Disease (CKD) Kidney and Bladder stones
Dialysis and Renal Care Urology/Urinary Tract Infections
Kidney Transplantation Geriatric-Genetic Kidney…
